Back to CVE records
High 8.7Published Aug 26, 2026

CVE-2026-47665Penpot: Stored XSS via comment content, innerHTML renders unsanitized HTML

Updated under an hour ago ()

Does this affect you?

It affects penpot. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Penpot is an open-source design and prototyping platform. In versions up to and including 2.14.3, Penpot is vulnerable to stored cross-site scripting through file comments, whose content is stored as raw text and rendered into the page with innerHTML without any sanitization. Because the backend applies only a length check and the frontend writes comment content directly through innerHTML, any team member who can comment on a shared file can embed HTML such as an image error handler or script that executes in the browser of every other collaborator. The attack is passive: any user who opens the comments panel on the affected file triggers script execution on the Penpot origin, allowing theft of session cookies, actions performed as the victim, and access to their files and projects. This issue is fixed in version 2.15.3.

CVSS
8.7 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N
Weakness (CWE)
CWE-79
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Aug 27, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
penpot penpot
penpot:penpot (from the name)
before 2.15.3
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.